| Literature DB >> 29789949 |
Sharon Elad1, Praveen Arany2, Rene-Jean Bensadoun3, Joel B Epstein4,5,6, Andrei Barasch7, Judith Raber-Durlacher8,9.
Abstract
This commentary attempts to clarify the setting of photobiomodulation (BPM) therapy in the management of oral mucositis. The suggested dose range balances efficacy data with our current understanding about PBM safety. The literature about the molecular basis of photobiomodulation and its controversial relationship to malignant transformation is briefly presented.Entities:
Keywords: Cancer; Laser therapy; Light; Low-level; Oral mucositis; Photobiomodulation; Treatment
Mesh:
Year: 2018 PMID: 29789949 DOI: 10.1007/s00520-018-4262-6
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603